Virtu Financial’s Oasmia Pharmaceutical AB OASM Stock Holding History

Virtu Financial’s Portfolio OASM Stock Details OASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11,517	Closed	-$49K	–	2194
2018 Q3	$49K	Buy	+11,517	New	+$24.1K	﹤0.01%	1306

Other funds holding OASM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Virtu Financial's OASM Position: Q4 2018 in Review

Virtu Financial sold out of Oasmia Pharmaceutical AB (OASM) in Q4 2018, closing a stake of 11,517 shares — an estimated $49K sold.

Virtu Financial first reported a position in OASM in Q3 2018 and held it in 1 quarter. The position peaked at $49K in Q3 2018. 5 funds tracked by Wall St. Rank hold OASM as of Q4 2018.

Virtu Financial reported no remaining Oasmia Pharmaceutical AB position as of Q4 2018 after selling out during the quarter.
Virtu Financial sold 11,517 Oasmia Pharmaceutical AB shares in Q4 2018, an estimated $49K.
Virtu Financial first reported a position in Oasmia Pharmaceutical AB in Q3 2018 and held it in 1 quarter.
Virtu Financial's Oasmia Pharmaceutical AB position peaked at $49K in Q3 2018.
5 funds tracked by Wall St. Rank held Oasmia Pharmaceutical AB as of Q4 2018.

Based on Virtu Financial's 13F filing for Q4 2018, filed 16 Jan 2019.